[Is atypical sodium current related to arterial pathophysiology?].
Primary cultured human coronary myocytes, derived from patients with end-stage heart failure (NYHA, classes III and IV) caused by an ischemic disease and undergoing heart transplantation, express a voltage-gated tetrodotoxin-sensitive sodium current (INa). This current has atypical electrophysiological and pharmacological properties and regulates intracellular sodium ([Na+]i) and calcium ([Ca2+]i). Our work is aimed at identifying its role and regulation of expression during pathophysiology. We currently investigate whether INa is expressed in vascular smooth muscles cells (VSMCs) isolated from either healthy or diseased (atheromatous) arteries in human and, in parallel, in pig, rabbit and rat. Cells were enzymatically isolated, primary cultured and macroscopic INa were recorded using the whole cell patch clamp technique. We found that INa is expressed in VSMCs grown from human aortic (90%; n = 48) and pulmonary (44%; n = 16) arteries and in the human aortic cell line HAVSMC (94%; n = 27). INa was also detected in pig coronary (60%; n = 25) and rabbit aortic (47%; n = 15) VSMCs, but not in rat aortic myocytes (n = 30). These different INa were activated at similar range of potentials (approximately -45 mV), had similar sensitivity to tetrodotoxin (IC50 around 5 nM) and similar density (2 to 4 pA/pF). Their expression was related to cell dedifferentiation in vitro. However, INa was observed more frequently in human myocytes derived from diseased arteries (ischemic cardiopathy) than in those derived from healthy tissues (dilated cardiopathy). In conclusion, INa may contribute to increase the basal arterial contractility and play a role in pathological situations including hypertension.
Choby
C
C
CNRS UPR-1142, IGH, Montpellier.
Quignard
J F
JF
Boccara
G
G
Mangoni
M
M
Frapier
J M
JM
Albat
B
B
Nargeot
J
J
Richard
S
S
D000200:Action Potentials / Q000502:physiology; D000818:Animals; D001011:Aorta / Q000503:physiopathology*; D001018:Aortic Diseases / Q000503:physiopathology; D001157:Arterial Occlusive Diseases / Q000503:physiopathology; D001161:Arteriosclerosis / Q000503:physiopathology*; D002311:Cardiomyopathy, Dilated / Q000503:physiopathology; D002454:Cell Differentiation; D002478:Cells, Cultured; D003324:Coronary Artery Disease / Q000503:physiopathology; D003331:Coronary Vessels / Q000503:physiopathology*; D004195:Disease Models, Animal; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D015640:Ion Channel Gating / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000503:physiopathology*; D017202:Myocardial Ischemia / Q000503:physiopathology; D018408:Patch-Clamp Techniques; D011651:Pulmonary Artery / Q000503:physiopathology*; D011817:Rabbits; D051381:Rats; D017208:Rats, Wistar; D015222:Sodium Channels / Q000502:physiology*; D013552:Swine; D013779:Tetrodotoxin / Q000494:pharmacology; D014666:Vasomotor System / Q000503:physiopathology
D015222:Sodium Channels; D013779:Tetrodotoxin